Bone Biologics Shareholder Meeting
Bone Biologics Corp held its Annual Meeting of stockholders on September 28, 2026, where shareholders elected four directors and ratified Weinberg & Company, P.A. as the independent auditor. Stockholders also approved a potential reverse stock split at a ratio between 1-for-2 and 1-for-10 and authorized the potential issuance of shares underlying warrants in excess of 20% of outstanding stock to comply with Nasdaq rules.